Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Movano ( (MOVE) ) just unveiled an announcement.
On August 21, 2025, Movano Inc. received a notice from Nasdaq for failing to file its Form 10-Q for the quarter ended June 30, 2025, by the due date of August 14, 2025, putting the company out of compliance with Nasdaq’s listing rules. Movano has appealed the delisting determination and presented a compliance plan to the Nasdaq Hearing Panel, but there is no assurance that their request to stay the suspension of trading will be granted, which could impact their Nasdaq listing status.
The most recent analyst rating on (MOVE) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on Movano stock, see the MOVE Stock Forecast page.
Spark’s Take on MOVE Stock
According to Spark, TipRanks’ AI Analyst, MOVE is a Underperform.
Movano’s stock faces significant challenges primarily due to its weak financial performance, marked by negative profitability and cash flow issues. The technical analysis indicates a bearish trend with poor market momentum, and valuation metrics are unfavorably low. Overall, the stock needs substantial improvement in operational efficiency and market perception to enhance its attractiveness.
To see Spark’s full report on MOVE stock, click here.
More about Movano
Founded in 2018, Movano Inc., operating as Movano Health, is a company focused on developing healthcare solutions that integrate medical-grade data into wearable devices. Their flagship product, the Evie Ring, exemplifies their innovative approach to providing personalized health insights through modern and flexible form factors.
Average Trading Volume: 551,086
Technical Sentiment Signal: Sell
Current Market Cap: $4.17M
For a thorough assessment of MOVE stock, go to TipRanks’ Stock Analysis page.